Sesen Bio, Inc. (SESN) financial statements (2023 and earlier)

Company profile

Business Address 245 FIRST STREET
CAMBRIDGE, MA 02142
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments162,63652,38948,12150,42214,68025,34236,079
Cash and cash equivalents162,63652,38948,12150,42214,68025,34236,079
Restricted cash and investments 3,000     
Receivables24,493      
Other undisclosed current assets18,4767,4786,3261,334301585232
Total current assets:205,60562,86754,44751,75614,98125,92736,311
Noncurrent Assets
Property, plant and equipment43123238321522796407
Intangible assets, net (including goodwill)27,76459,46459,46459,46459,46477,364 
Goodwill13,06413,06413,06413,06413,06416,864 
Intangible assets, net (excluding goodwill)14,70046,40046,40046,40046,40060,500 
Prepaid expense7,192      
Restricted cash and investments20202020101094
Other noncurrent assets123349196 120 13
Total noncurrent assets:35,14259,95659,91859,80560,11678,170514
TOTAL ASSETS:240,747122,823114,365111,56175,097104,09736,825
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities11,1087,0758,0716,1134,7203,4413,040
Accounts payable2,8533,1021,9021,3679071,6671,246
Accrued liabilities8,2553,9736,1694,7463,8131,7741,794
Deferred revenue 1,500 
Debt      4,134
Due to related parties     114 
Deferred revenue and credits 425406
Other liabilities460489446    
Other undisclosed current liabilities 8,985     
Total current liabilities:11,56818,0498,5176,1134,7203,9807,580
Noncurrent Liabilities
Long-term debt and lease obligation      9,763
Long-term debt, excluding current maturities      9,763
Liabilities, other than long-term debt57,469114,001132,54848,71339,81561,435423
Deferred revenue1,5001,500 
Deferred tax liabilities, net  16,335 
Deferred income tax liabilities3,96912,52812,528
Other liabilities 118 313215 423
Business combination, contingent consideration, liability52,00099,855120,02048,40039,60045,100 
Total noncurrent liabilities:57,469114,001132,54848,71339,81561,43510,186
Total liabilities:69,037132,050141,06554,82644,53565,41517,766
Stockholders' equity
Stockholders' equity attributable to parent171,710(9,227)(26,700)44,20718,03438,67718,944
Common stock19914010777352520
Additional paid in capital487,768306,554266,717230,154170,330161,963144,126
Accumulated deficit(316,257)(315,921)(293,524)(186,024)(152,331)(123,311)(125,202)
Total stockholders' equity:171,710(9,227)(26,700)44,20718,03438,67718,944
Other undisclosed liabilities and equity   12,52812,5285115
TOTAL LIABILITIES AND EQUITY:240,747122,823114,365111,56175,097104,09736,825

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues26,54411,236  425406490
Revenue, net42529,981990
Gross profit:26,54411,236  425406490
Operating expenses(35,093)(32,313)(108,491)(34,500)(29,680)(27,115)(36,186)
Other undisclosed operating income     29,575500
Operating income (loss):(8,549)(21,077)(108,491)(34,500)(29,255)2,866(35,196)
Nonoperating income (expense)(60)125991807226(970)1,744
Other nonoperating income (expense)(60)125991807226(723)3,139
Interest and debt expense     (221) 
Other undisclosed income from continuing operations before equity method investments, income taxes     221 
Income (loss) from continuing operations before income taxes:(8,609)(20,952)(107,500)(33,693)(29,029)1,896(33,452)
Income tax expense (benefit)8,273(1,445)   (5) 
Net income (loss) attributable to parent:(336)(22,397)(107,500)(33,693)(29,029)1,891(33,452)
Preferred stock dividends and other adjustments (147)     
Net income (loss) available to common stockholders, diluted:(336)(22,544)(107,500)(33,693)(29,029)1,891(33,452)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss):(336)(22,397)(107,500)(33,693)(29,029)1,891(33,452)
Comprehensive income (loss), net of tax, attributable to parent:(336)(22,397)(107,500)(33,693)(29,029)1,891(33,452)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: